21st Century Oncology is proud to announce that its cancer treatment centers in Central Florida have earned the prestigious American College of Radiation Oncology (ACRO) accreditation. The Ocala and Beverly Hills centers earned the distinction after a thorough, objective and impartial peer review of both facilities.
“This distinction is an honor for our practices,” said Ravi Sandrapaty, M.D., who is board certified by the American Board of Radiology in Radiation Oncology and is the medical director of 21st Century Oncology’s Central Florida locations. “Every day our team works tirelessly to provide the utmost care for our patients in both the Ocala and Beverly Hills facilities.”
ACRO’s mission is to strive to ensure the highest quality of care for radiation therapy patients, and promote success in the practice of radiation oncology through education, responsible socioeconomic advocacy and integration of science and technology into clinical practice.
As part of their mission, ACRO began their practice accreditation program in 1995, which consisted of practice standards within the field of radiation oncology.
Today, accreditation from ACRO remains a voluntary process in which professional peers identify standards indicative of a quality practice through audits conducted to assure that these standards are followed, including on-site visits by physics and administrative surveyors.
“This accreditation is proof that we have been successful in our commitment to excellence, but it does not stop here,” said Dr. Sandrapaty. “Every day we are reminded of our purpose through our interactions with patients. They are our motivation to continuously strive for high-quality care.”
During the review process, 21st Century Oncology’s locations in Central Florida were judged on accuracy in patients’ charts, including medical information, quality of documentation and case management, calibration of all machines, radiation safety measures and a review of all processes and work flow within the facility.
21st Century Oncology is the largest global, physician led provider of integrated cancer care services. The company offers a comprehensive range of cancer treatment services focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of September 30, 2016, the company operated 180 treatment centers, including 144 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.